For patients with nonproliferative diabetic retinopathy, treating early with aflibercept may slow disease progression, but it does not appear to positively impact vision long-term. Source: AAO
Nanoparticles added to injections may prevent corneal graft rejection, the retinal microvasculature is affected by COVID-19 infection, and increased genetic risk of glaucoma accelerates visual field loss. Source: AAO
Acute posterior vitreous detachment (PVD) often presents with concurrent complications, but many eyes continue to experience retinal complications months after diagnosis. Source: AAO
Even 15 years after the initial procedure, corneal crosslinking appears to safely stabilize the cornea without the need for retreatment in most patients with progressive keratoconus. Source: AAO
A novel predictive scoring system aims to help quantify the risk of failure of plaque brachytherapy, a common treatment option for posterior uveal melanoma. Source: AAO
A small percentage of children who are seen for increased cup–disc ratio will develop glaucoma, most commonly in the first months following presentation. Source: AAO
A meta-analysis suggests that visual and anatomic outcomes after macular detachment surgery worsen the longer a patient experiences symptoms before seeking treatment. Source: AAO
Wavefront-guided photorefractive keratectomy (PRK) was found not only to be a safe and successful treatment option but also one that left 99% of patients highly satisfied. Source: AAO
In comparison with spectral-domain OCT (SD-OCT), Pentacam OCT appears to underestimate corneal thickness following customized corneal crosslinking to treat keratoconus. Source: AAO
Centrally located corneal scarring due to herpes simplex virus appears to significantly decrease corneal nerve regenerative abilities in comparison to scarring located more peripherally. Source: AAO